Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Long-Term Biosimilar Sustainability Is At A Tipping Point, Report Says
New Policy Levers Are Needed For A Balanced And Sustainable Biosimilar Market
Feb 08 2024
•
By
Urtė Fultinavičiūtė
Biosimilars may save $180bn between 2023 and 2027 • Source: Shutterstock
More from Biosimilars
More from Products